FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

AuroMedics Pharma Lidocaine HCl Injection Recall

Lidocaine HCl Injection, USP, 2% 100 mg/5 mL (20 mg/mL), Preservative-Free, packaged in…

AuroMedics Pharma LLC · East Windsor, NJ

Risk level
Class II
Reported by FDA
Dec 4, 2019
Recall ID
D-0573-2020
Check your lot numberHow we source this data

Summary

AuroMedics Pharma recalled Lidocaine HCl Injection starting Nov 11, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0573-2020 on Dec 4, 2019. Reason: Presence of Foreign Substance: Foreign material found inside the vial. Status: Terminated.

Why it was recalled

Presence of Foreign Substance: Foreign material found inside the vial.

Product description

Lidocaine HCl Injection, USP, 2% 100 mg/5 mL (20 mg/mL), Preservative-Free, packaged in 10 x 5 mL Single Dose Vials per carton, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-165-05.

Lot numbers, UPCs & expiration codes

Batch #: CLC190049, Exp 02/2022

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0573-2020
Classification
Class II
Status
Terminated
Recall initiated
Nov 11, 2019
FDA report date
Dec 4, 2019
Quantity
111,850 vials
Recall type
Voluntary: Firm initiated
Recalling firm
AuroMedics Pharma LLC

Original FDA data

Every field from FDA enforcement report D-0573-2020, exactly as published.

Show all FDA fields
City
East Windsor
State
NJ
Status
Terminated
Country
United States
Event ID
84241
Address
279 Princeton Hightstown Rd
Code information
Batch #: CLC190049, Exp 02/2022
Postal code
08520-1401
Report date
Dec 4, 2019
Product type
Drugs
Recall number
D-0573-2020
Classification
Class II
Recalling firm
AuroMedics Pharma LLC
Product quantity
111,850 vials
Termination date
Nov 17, 2020
Reason for recall
Presence of Foreign Substance: Foreign material found inside the vial.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lidocaine HCl Injection, USP, 2% 100 mg/5 mL (20 mg/mL), Preservative-Free, packaged in 10 x 5 mL Single Dose Vials per carton, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-165-05.
Distribution pattern
Nationwide in the USA
Recall initiation date
Nov 11, 2019
Initial firm notification
Letter
Center classification date
Dec 5, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0573-2020, published Dec 4, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls